Keros Therapeutics, Inc. (KROS)
11.95
+0.31
(+2.66%)
USD |
NASDAQ |
Oct 09, 16:00
11.95
0.00 (0.00%)
Pre-Market: 08:47
Keros Therapeutics Price : 11.95 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 11.58 | 12.26 | 11.49 | 11.95 | 194393.0 |
| Oct 08, 2026 | 11.13 | 11.76 | 10.99 | 11.64 | 245658.0 |
| Oct 07, 2026 | 10.81 | 11.34 | 10.81 | 11.21 | 195963.0 |
| Oct 06, 2026 | 11.56 | 11.63 | 10.95 | 11.01 | 185318.0 |
| Oct 05, 2026 | 11.38 | 11.56 | 11.07 | 11.52 | 132408.0 |
| Oct 02, 2026 | 11.38 | 11.44 | 11.01 | 11.36 | 231534.0 |
| Oct 01, 2026 | 11.38 | 11.44 | 11.08 | 11.26 | 140170.0 |
| Sep 30, 2026 | 11.25 | 11.58 | 11.16 | 11.40 | 131222.0 |
| Sep 29, 2026 | 11.24 | 11.46 | 11.15 | 11.19 | 118350.0 |
| Sep 28, 2026 | 11.33 | 11.41 | 10.92 | 11.28 | 208643.0 |
| Sep 25, 2026 | 11.54 | 11.70 | 11.28 | 11.62 | 216073.0 |
| Sep 24, 2026 | 11.60 | 11.60 | 10.97 | 11.55 | 284438.0 |
| Sep 23, 2026 | 11.68 | 11.82 | 11.47 | 11.63 | 157540.0 |
| Sep 22, 2026 | 11.54 | 12.05 | 11.43 | 11.73 | 189818.0 |
| Sep 21, 2026 | 11.31 | 11.60 | 11.08 | 11.48 | 120722.0 |
| Sep 18, 2026 | 11.32 | 11.40 | 11.10 | 11.19 | 302476.0 |
| Sep 17, 2026 | 10.87 | 11.39 | 10.83 | 11.36 | 274090.0 |
| Sep 16, 2026 | 11.23 | 11.23 | 10.70 | 10.74 | 273994.0 |
| Sep 15, 2026 | 11.16 | 11.21 | 10.72 | 11.17 | 199982.0 |
| Sep 14, 2026 | 11.10 | 11.34 | 10.98 | 11.21 | 342164.0 |
| Sep 11, 2026 | 11.25 | 11.34 | 11.02 | 11.08 | 143827.0 |
| Sep 10, 2026 | 11.16 | 11.20 | 11.00 | 11.17 | 128792.0 |
| Sep 09, 2026 | 11.48 | 11.82 | 11.21 | 11.31 | 188508.0 |
| Sep 08, 2026 | 11.16 | 11.31 | 10.98 | 11.17 | 73047.00 |
| Sep 04, 2026 | 11.03 | 11.40 | 11.02 | 11.32 | 65636.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 112.79 |
| Viking Therapeutics, Inc. | 28.51 |
| ACADIA Pharmaceuticals, Inc. | 19.78 |
| Alnylam Pharmaceuticals, Inc. | 232.68 |
| Anika Therapeutics, Inc. | 19.58 |
Price Related Metrics
| PS Ratio | 21.34 |
| Price to Book Value | 0.9032 |
| Earnings Yield | -30.96% |
| Market Cap | 236.94M |